Literature DB >> 19114557

An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair.

Jaan-Olle Andressoo1, Geert Weeda, Jan de Wit, James R Mitchell, Rudolf B Beems, Harry van Steeg, Gijsbertus T J van der Horst, Jan H Hoeijmakers.   

Abstract

Patients carrying mutations in the XPB helicase subunit of the basal transcription and nucleotide excision repair (NER) factor TFIIH display the combined cancer and developmental-progeroid disorder xeroderma pigmentosum/Cockayne syndrome (XPCS). Due to the dual transcription repair role of XPB and the absence of animal models, the underlying molecular mechanisms of XPB(XPCS) are largely uncharacterized. Here we show that severe alterations in Xpb cause embryonic lethality and that knock-in mice closely mimicking an XPCS patient-derived XPB mutation recapitulate the UV sensitivity typical for XP but fail to show overt CS features unless the DNA repair capacity is further challenged by crossings to the NER-deficient Xpa background. Interestingly, the Xpb(XPCS) Xpa double mutants display a remarkable interanimal variance, which points to stochastic DNA damage accumulation as an important determinant of clinical diversity in NER syndromes. Furthermore, mice carrying the Xpb(XPCS) mutation together with a point mutation in the second TFIIH helicase Xpd are healthy at birth but display neonatal lethality, indicating that transcription efficiency is sufficient to permit embryonal development even when both TFIIH helicases are crippled. The double-mutant cells exhibit sensitivity to oxidative stress, suggesting a role for endogenous DNA damage in the onset of XPB-associated CS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114557      PMCID: PMC2643825          DOI: 10.1128/MCB.01229-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Starvation response in mouse liver shows strong correlation with life-span-prolonging processes.

Authors:  Matthias Bauer; Anne C Hamm; Melanie Bonaus; Andrea Jacob; Jens Jaekel; Hubert Schorle; Michael J Pankratz; Joerg D Katzenberger
Journal:  Physiol Genomics       Date:  2004-04-13       Impact factor: 3.107

2.  Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage (Version 6).

Authors:  Errol C Friedberg; Lisiane B Meira
Journal:  DNA Repair (Amst)       Date:  2004-12-02

3.  Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.

Authors:  J H Robbins; K H Kraemer; M A Lutzner; B W Festoff; H G Coon
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning.

Authors:  J McWhir; J Selfridge; D J Harrison; S Squires; D W Melton
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

5.  TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair.

Authors:  G S Winkler; S J Araújo; U Fiedler; W Vermeulen; F Coin; J M Egly; J H Hoeijmakers; R D Wood; H T Timmers; G Weeda
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor.

Authors:  E Citterio; V Van Den Boom; G Schnitzler; R Kanaar; E Bonte; R E Kingston; J H Hoeijmakers; W Vermeulen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome.

Authors:  G Weeda; R C van Ham; W Vermeulen; D Bootsma; A J van der Eb; J H Hoeijmakers
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

8.  DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor.

Authors:  L Schaeffer; R Roy; S Humbert; V Moncollin; W Vermeulen; J H Hoeijmakers; P Chambon; J M Egly
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

9.  Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage.

Authors:  Harm de Waard; Jan de Wit; Jaan-Olle Andressoo; Conny T M van Oostrom; Bente Riis; Allan Weimann; Henrik E Poulsen; Harry van Steeg; Jan H J Hoeijmakers; Gijsbertus T J van der Horst
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 10.  Cockayne syndrome: review of 140 cases.

Authors:  M A Nance; S A Berry
Journal:  Am J Med Genet       Date:  1992-01-01
View more
  29 in total

Review 1.  New approaches for modelling sporadic genetic disease in the mouse.

Authors:  Elizabeth M C Fisher; Eva Lana-Elola; Sheona D Watson; George Vassiliou; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2009 Sep-Oct       Impact factor: 5.758

2.  The XBP-Bax1 helicase-nuclease complex unwinds and cleaves DNA: implications for eukaryal and archaeal nucleotide excision repair.

Authors:  Christophe Rouillon; Malcolm F White
Journal:  J Biol Chem       Date:  2010-02-06       Impact factor: 5.157

Review 3.  Understanding nucleotide excision repair and its roles in cancer and ageing.

Authors:  Jurgen A Marteijn; Hannes Lans; Wim Vermeulen; Jan H J Hoeijmakers
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 4.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

5.  From the transcription of genes involved in ectodermal dysplasias to the understanding of associated dental anomalies.

Authors:  V Laugel-Haushalter; A Langer; J Marrie; V Fraulob; B Schuhbaur; M Koch-Phillips; P Dollé; A Bloch-Zupan
Journal:  Mol Syndromol       Date:  2012-09-27

6.  Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.

Authors:  Mohsen Hosseini; Walid Mahfouf; Martin Serrano-Sanchez; Houssam Raad; Ghida Harfouche; Marc Bonneu; Stephane Claverol; Frederic Mazurier; Rodrigue Rossignol; Alain Taieb; Hamid Reza Rezvani
Journal:  J Invest Dermatol       Date:  2014-12-01       Impact factor: 8.551

7.  Defective Hfp-dependent transcriptional repression of dMYC is fundamental to tissue overgrowth in Drosophila XPB models.

Authors:  Jue Er Amanda Lee; Naomi C Mitchell; Olga Zaytseva; Arjun Chahal; Peter Mendis; Amandine Cartier-Michaud; Linda M Parsons; Gretchen Poortinga; David L Levens; Ross D Hannan; Leonie M Quinn
Journal:  Nat Commun       Date:  2015-06-15       Impact factor: 14.919

8.  Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Authors:  Ivana Rybanská; Ján Gursky; Miriam Fasková; Edmund P Salazar; Erika Kimlícková-Polakovicová; Karol Kleibl; Larry H Thompson; Miroslav Pirsel
Journal:  Mutagenesis       Date:  2009-11-25       Impact factor: 3.000

9.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Authors:  Joseph Vijai; Sabine Topka; Danylo Villano; Vignesh Ravichandran; Kara N Maxwell; Ann Maria; Tinu Thomas; Pragna Gaddam; Anne Lincoln; Sarah Kazzaz; Brandon Wenz; Shai Carmi; Kasmintan A Schrader; Steven N Hart; Steve M Lipkin; Susan L Neuhausen; Michael F Walsh; Liying Zhang; Flavio Lejbkowicz; Hedy Rennert; Zsofia K Stadler; Mark Robson; Jeffrey N Weitzel; Susan Domchek; Mark J Daly; Fergus J Couch; Katherine L Nathanson; Larry Norton; Gad Rennert; Kenneth Offit
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

10.  Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice.

Authors:  Monique C de Waard; Ingrid van der Pluijm; Nils Zuiderveen Borgesius; Laura H Comley; Elize D Haasdijk; Yvonne Rijksen; Yanto Ridwan; Gerben Zondag; Jan H J Hoeijmakers; Ype Elgersma; Thomas H Gillingwater; Dick Jaarsma
Journal:  Acta Neuropathol       Date:  2010-07-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.